Clinical Trial Update: Nirogacestat in Ovarian Granulosa Cell Tumors [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Nirogacestat in ovarian granulosa cell tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Ovarian Granulosa Cell Tumor
• Ovarian Granulosa-stromal Tumor

Drugs mentioned

• Nirogacestat (nirogacestat)

Snippet

Sponsor: SpringWorks Therapeutics, Inc. | Conditions: Ovarian Granulosa-Stromal Tumor, Ovarian Granulosa Cell Tumor | Phase 2 | Status: COMPLETED